Recombinant Schizosaccharomyces pombe Transcription elongation factor spt5 (spt5), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We preferentially ship the available format. For specific format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult local distributors for specific times. Proteins are shipped with blue ice packs. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage state, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your desired tag type, and we will prioritize its development.
Synonyms
spt5; SPAC23C4.19; Transcription elongation factor spt5; Chromatin elongation factor spt5
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
Target Names
spt5
Uniprot No.

Target Background

Function
The spt4-spt5 complex regulates transcription elongation, playing roles in both activation and inhibition. It contributes to the stability of RNA polymerase II on chromatin during elongation, but not to its translocation ability.
Gene References Into Functions
1. Spt5 is essential for normal RNA synthesis rate and RNAPII distribution across transcription units. (PMID: 28366642) 2. Roles of Spt5 phosphorylation sites in co-transcriptional histone modifications. (PMID: 26275777) 3. Pct1 binding to Spt5 CTD is inhibited by threonine phosphorylation. (PMID: 25414009) 4. Fission yeast GTase binds Spt5 CTD at a distinct site in the OB-fold domain, interacting with Trp4 of the Spt5 repeat T(1)PAW(4)NSGSK. (PMID: 24939935) 5. Spt5 CTD phosphorylation plays a positive role in Pol II transcription elongation in fission yeast, separate from capping enzyme interactions. (PMID: 20231361)
Database Links
Protein Families
SPT5 family
Subcellular Location
Nucleus.

Q&A

What is the domain organization of S. pombe Spt5 and how does it compare to orthologs in other species?

S. pombe Spt5 is a 990-amino acid protein with a highly organized structure that includes several functional domains. The protein contains a highly structured N-terminal region that interacts with Spt4, followed by multiple KOW (Kyrpides, Ouzounis, Woese) domains that facilitate interactions with RNA polymerase II and nucleic acids. One of the most distinctive features of S. pombe Spt5 is its exceptionally regular carboxyl-terminal domain (CTD) composed of 18 nonapeptide repeats, which is more regular than that found in other species .

What experimental approaches can be used to purify recombinant S. pombe Spt5 with optimal biological activity?

Purification of recombinant S. pombe Spt5 with retained biological activity requires careful consideration of expression systems and purification conditions. The recommended protocol involves:

  • Expression system selection: While E. coli systems can be used for expressing partial domains, full-length active Spt5 is best expressed in eukaryotic systems such as insect cells (Sf9) or yeast systems. Co-expression with Spt4 significantly improves solubility and stability.

  • Affinity purification strategy: A dual-tag approach is highly effective, using His6 and either GST or MBP tags with a TEV protease cleavage site. This allows for sequential affinity purification steps.

  • Buffer optimization: Including 5% glycerol, 1mM DTT, and 0.1mM ZnCl2 in purification buffers helps maintain protein stability and activity, especially important for preserving the zinc-binding domain interactions.

  • Complex purification: For optimal activity, purify Spt5 as part of the Spt5-Spt4 heterodimer complex. This has been characterized as the core functional unit and demonstrates greater stability and biological activity in in vitro transcription assays .

  • Activity verification: Following purification, verification of biological activity can be performed using in vitro transcription elongation assays with purified S. pombe RNA polymerase II.

How can the auxin-inducible degron (AID) system be optimized for studying Spt5 function in S. pombe?

The auxin-inducible degron (AID) system has proven highly effective for studying essential genes like Spt5. For optimal results with S. pombe Spt5, consider the following methodological refinements:

  • AID tag placement: C-terminal tagging of Spt5 with the AID degron is preferable as it minimizes interference with N-terminal functional domains and the Spt4 interaction interface.

  • TIR1 expression control: Two approaches have shown success:

    • β-estradiol-triggered artificial promoter to induce TIR1 transcription, which reduces leaky degradation

    • Constitutive expression using the ADH1 promoter, which provides consistent degradation kinetics

  • Auxin concentration and timing: Optimal depletion of Spt5 can be achieved using 0.5-0.75 mM IAA (indole-3-acetic acid), with significant protein depletion occurring within 30-60 minutes of treatment .

  • Enhanced system modifications: Consider using the modified OsTIR1F74A with synthetic auxin derivative 5-Adamantyl-IAA (5-Ad-IAA), which reduces background degradation and lowers the concentration needed to trigger degradation .

  • Validation controls: Always include:

    • Western blot confirmation of depletion efficiency

    • Untreated Spt5-AID strain controls

    • Wild-type strains with auxin treatment to control for auxin toxicity effects

  • Growth condition adjustments: When performing depletion experiments, growth medium composition and temperature may need adjustment, as Spt5 depletion causes severe growth defects and temperature sensitivity .

This approach has enabled researchers to observe that Spt5 depletion leads to dramatic changes in RNAPII localization, with reduced levels and relative accumulation over the first ~500 bp of genes, suggesting Spt5 is required for transcription past a barrier region .

What are the most effective genomic approaches to study Spt5's impact on transcription genome-wide?

Four complementary genomic approaches have proven particularly valuable for comprehensive analysis of Spt5's role in transcription:

  • ChIP-seq for RNAPII and Spt5: This approach maps the genome-wide distribution of both Spt5 and RNA polymerase II before and after Spt5 depletion. Critical methodological considerations include:

    • Crosslinking optimization (1% formaldehyde for 15 minutes at room temperature)

    • Sonication parameters (achieving fragments of 200-300 bp)

    • Use of spike-in controls for accurate normalization between conditions

    • Sequential ChIP for detecting co-occupancy

  • NET-seq (Native Elongating Transcript sequencing): This technique maps the position of actively transcribing polymerases at nucleotide resolution by sequencing the 3' ends of nascent RNA. For Spt5 studies:

    • Include HA-tagging of RNA polymerase (typically the A135 subunit for Pol I or Rpb1 for Pol II)

    • Optimize immunoprecipitation conditions to maintain native elongation complexes

    • Pay careful attention to library preparation to preserve the identity of the 3' nucleotide

  • RNA-seq with strand specificity: This approach can detect both sense and antisense transcription events. Methodological refinements include:

    • rRNA depletion rather than poly(A) selection to capture nascent and unstable transcripts

    • Strand-specific library preparation to differentiate sense and antisense transcription

    • Time-course analysis following Spt5 depletion to detect primary versus secondary effects

  • Real-time nascent RNA synthesis assays: For measuring immediate effects on transcription rates:

    • RT-qPCR targeting short-lived RNA species such as the ITS1 region of rRNA

    • BrUTP incorporation followed by immunoprecipitation and sequencing

    • Run-on assays with labeled nucleotides

These approaches have revealed that Spt5 is crucial for maintaining normal rates of RNA synthesis and proper distribution of RNAPII across transcription units. They've also uncovered Spt5's role in preventing widespread antisense transcription that initiates within a barrier region approximately 500 bp downstream of promoters .

What techniques can be used to map the structural interactions between Spt4 and Spt5 in S. pombe?

Understanding the Spt4-Spt5 interaction interface requires a multi-faceted structural and biochemical approach:

  • Limited proteolysis and domain mapping: Trypsin-resistant domains can identify stable interaction interfaces. Research has successfully mapped a trypsin-resistant Spt4-binding domain within the Spt5 subunit .

  • Two-hybrid assays: Yeast two-hybrid analysis provides an in vivo readout of interaction strength. This approach has been used to assess the effects of 33 missense and truncation mutations on S. pombe Spt4 function and interaction with Spt5 .

  • Co-immunoprecipitation with truncation and point mutants: Systematic analysis of interaction domains using tagged proteins can map critical residues. This has identified the importance of:

    • Spt4 Zn²⁺-binding residues (Cys12, Cys15, Cys29, and Asp32)

    • Ser57, a conserved constituent of the Spt4-Spt5 interface

  • X-ray crystallography or Cryo-EM: While challenging, structural determination provides the most detailed view of interaction interfaces. The crystal structure of S. cerevisiae Spt4 fused to a fragment of Spt5 has provided valuable structural insights that can be applied to S. pombe orthologues .

  • Cross-linking mass spectrometry (XL-MS): This approach can identify interaction points between Spt4 and Spt5 in their native state by chemically cross-linking proximal amino acids followed by mass spectrometry analysis.

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This method can map changes in protein dynamics and solvent accessibility upon complex formation, revealing interaction surfaces between Spt4 and Spt5.

These approaches have collectively demonstrated that the S. pombe core Spt5-Spt4 complex exists as a heterodimer with specific interaction domains that can be targeted for further functional studies .

How does Spt5 depletion affect RNA polymerase II distribution across genes in S. pombe?

Spt5 depletion dramatically alters RNA polymerase II (RNAPII) distribution across the S. pombe genome in highly specific patterns:

These observations provide strong evidence that Spt5 functions globally as an essential elongation factor required for transcription past a barrier region approximately 500 bp downstream of the transcription start site, possibly representing a regulatory checkpoint in the transcription cycle .

What is the relationship between Spt5 and antisense transcription in S. pombe?

Spt5 plays a critical role in suppressing antisense transcription in S. pombe through several mechanisms:

  • Barrier region antisense initiation: Spt5 depletion results in widespread antisense transcription specifically initiating within the barrier region approximately 500 bp downstream of the transcription start site. This suggests that when RNAPII accumulates at this barrier in the absence of Spt5, it may facilitate antisense transcription initiation from the opposite strand .

  • Bidirectional antisense control: Two distinct patterns of antisense transcription emerge after Spt5 depletion:

    • Convergent antisense: Transcripts that initiate within genes and proceed toward the promoter

    • Divergent antisense: Transcripts that initiate near the promoter and proceed in the opposite direction from the sense transcript

  • Unique mechanism: The antisense transcription observed after Spt5 depletion appears to involve a mechanism distinct from other pathways. When tested against other known factors that affect antisense transcription (including Paf1 complex recruitment, H3K4 trimethylation, Spt6 function, and nuclear exosome activity), only Spt5 depletion produced the specific antisense transcription pattern at the tested genes (rif1+ and asn1) .

  • Complementation evidence: The antisense transcription phenotype can be reversed by complementation with wild-type Spt5, confirming the direct role of Spt5 in preventing antisense transcription .

This regulatory function of Spt5 appears to be conserved but with interesting species-specific variations. While divergent antisense transcription has been well-described in S. cerevisiae and mammalian cells, it has not been detected in S. pombe under normal conditions, suggesting that S. pombe may have evolved particularly strong mechanisms to suppress such transcription, with Spt5 playing a key role .

What is known about the function of the Spt5 CTD in S. pombe and how does it differ from other organisms?

The carboxyl-terminal domain (CTD) of S. pombe Spt5 has several distinctive features and functions:

  • Structural organization: S. pombe Spt5 possesses an exceptionally regular CTD composed of 18 nonapeptide repeats, which is more uniform and numerous than the CTD repeats found in other species .

  • Functional redundancy with Spt4: Genetic studies demonstrate that as few as three nonamer repeats of the Spt5 CTD are sufficient for S. pombe growth, but only when Spt4 is present. This suggests a functional redundancy between the Spt5 CTD and its interaction with Spt4 .

  • Synthetic lethality: The synthetic lethality of the spt5(1-835) spt4Δ double mutant at 34°C provides evidence that the interaction of Spt4 with the central domain of Spt5 functionally overlaps with the Spt5 CTD, revealing multiple layers of functional redundancy in the system .

  • Transcriptional effects: Studies show that deletion of the CTD (spt5-ΔCTR) has only minor effects on mRNA levels and splicing compared to complete Spt5 depletion, suggesting that the CTD likely plays a modulatory rather than essential role in basic transcription elongation .

  • Species differences: Unlike S. cerevisiae, where the Spt5 CTD phosphorylation by Bur1/Bur2 kinase is well-characterized, the regulatory mechanisms governing S. pombe Spt5 CTD function are less well understood and may involve different kinases or modification patterns.

  • Protein interaction platform: While the detailed interactome of the S. pombe Spt5 CTD awaits comprehensive characterization, by analogy with other systems, it likely serves as a platform for recruiting factors involved in various co-transcriptional processes, such as RNA processing, chromatin modification, and termination.

This functional flexibility of the Spt5 CTD, particularly its ability to be largely dispensable when Spt4 is present, represents an important adaptation that may allow for more nuanced regulation of transcription elongation under different conditions .

How can researchers investigate the role of Spt5 in RNA Polymerase I transcription?

Investigating Spt5's role in RNA Polymerase I (Pol I) transcription requires specialized approaches due to the unique characteristics of rDNA transcription:

  • Auxin-inducible degron (AID) system optimization:

    • Tag Spt5 with AID and express TIR1 using either β-estradiol induction or constitutive promoters

    • Monitor IAA-induced Spt5 depletion via western blotting

    • Control for auxin toxicity effects with appropriate control strains

  • rRNA synthesis measurement:

    • Target the ITS1 (Internal Transcribed Spacer 1) region of rRNA using RT-qPCR as a reporter for nascent rRNA synthesis

    • This region is rapidly processed and degraded, making it an effective proxy for newly synthesized Pol I transcripts

    • Use the more stable 18S rRNA as a normalization control

  • Pol I-specific NET-Seq:

    • Tag the second largest subunit of Pol I (A135) with HA for immunoprecipitation

    • Perform NET-Seq to map Pol I transcription at nucleotide resolution

    • Analyze pause sites and sequence preferences in the context of Spt5 depletion

  • Comparative analysis of pause sites:

    • Generate DiffLogo analyses comparing Spt5-depleted and control samples

    • Focus on the nucleotide preferences at pause sites (positions -4 through 0)

    • Be aware that technical differences during library preparation can affect results

  • Growth phenotype analysis:

    • Monitor growth in liquid culture in the presence of IAA over time

    • Perform serial dilution spotting assays on solid media with and without IAA

    • These approaches can demonstrate the essential nature of Spt5 for rapid cell division

What methods can be employed to dissect the differential functions of Spt5 domains in various transcriptional processes?

Dissecting the domain-specific functions of Spt5 requires a comprehensive toolkit of genetic, biochemical, and molecular approaches:

  • Domain-specific mutant libraries:

    • Generate systematic alanine-scanning mutations across each domain

    • Create domain truncation/deletion series

    • Construct chimeric proteins swapping domains between species

    • Introduce specific mutations in key residues identified from structural studies

  • Differential complementation assays:

    • Deplete endogenous Spt5 using the AID system

    • Express domain mutants from plasmids

    • Assess rescue of different phenotypes (growth, antisense transcription, RNAPII distribution)

    • This approach can reveal which domains are required for specific functions

  • Genetic interaction mapping:

    • Screen for synthetic lethality or suppression between Spt5 domain mutants and other transcription factors

    • The synthetic lethality observed between spt5(1-835) and spt4Δ demonstrates the power of this approach

    • Expand to genome-wide screens using synthetic genetic array (SGA) technology

  • Domain-specific protein interaction profiling:

    • Perform BioID or APEX proximity labeling with different Spt5 domains

    • Use domain-specific yeast two-hybrid screens

    • Conduct pull-downs with recombinant domains followed by mass spectrometry

    • These approaches can identify domain-specific protein interaction networks

  • Domain-specific ChIP-seq:

    • Create a series of domain-tagged Spt5 constructs

    • Perform ChIP-seq to map the genomic localization patterns of each domain

    • Correlate domain occupancy with specific transcriptional states or gene features

  • In vitro reconstitution assays:

    • Purify recombinant Spt5 with domain mutations

    • Assess effects on defined biochemical activities (RNAPII binding, nucleic acid interactions)

    • Measure impacts on transcription elongation rates and processivity

This multi-faceted approach has revealed, for example, that the Spt5 CTD is largely dispensable when Spt4 is present, highlighting functional redundancy between domains and interacting partners .

How can researchers investigate the molecular mechanism of the transcription barrier that requires Spt5 for efficient passage?

Investigating the molecular nature of the Spt5-dependent transcription barrier at approximately 500 bp requires sophisticated experimental approaches:

  • High-resolution mapping of the barrier:

    • Perform NET-seq with nucleotide resolution before and after Spt5 depletion

    • Identify precise positions of RNAPII accumulation using peak-calling algorithms

    • Analyze the sequence context surrounding barrier regions genome-wide

    • Look for common sequence motifs or structural features at barrier sites

  • Regional deletion analysis:

    • Generate a series of deletions within the barrier region of model genes

    • Assess RNAPII distribution by ChIP-seq after these deletions

    • Research has shown that deletions of the barrier region alter RNAPII distribution on the sense strand, suggesting that this region normally requires Spt5 to stimulate elongation

  • Nucleosome architecture analysis:

    • Map nucleosome positioning before and after Spt5 depletion using MNase-seq

    • Correlate barrier positions with nucleosome locations and stability

    • Investigate histone modifications at barrier regions using ChIP-seq

    • Test if chromatin remodelers genetically interact with Spt5 at barriers

  • RNA structure analysis:

    • Perform SHAPE-seq or similar RNA structure probing on nascent transcripts

    • Determine if RNA secondary structures form at barrier regions

    • Test whether these structures impede RNAPII progression in the absence of Spt5

  • Elongation complex stability assays:

    • Purify elongation complexes stalled at barrier regions

    • Measure their stability and susceptibility to backtracking or arrest

    • Test if Spt5 addition stabilizes these complexes in vitro

  • Real-time single-molecule approaches:

    • Utilize optical tweezers or magnetic trap experiments

    • Measure transcription dynamics through barrier sequences

    • Directly observe the effect of Spt5 addition on elongation rates and pausing

  • Factor recruitment analysis:

    • Perform ChIP-seq for various elongation factors at barrier regions

    • Determine if specific factors are recruited by Spt5 to facilitate barrier passage

    • Test genetic interactions between these factors and Spt5

These approaches can collectively elucidate the molecular nature of the transcription barrier and the mechanism by which Spt5 facilitates its traversal, building on the observation that barrier regions appear to be sites at which Spt5 normally stimulates elongation .

What are the most effective strategies for generating and validating Spt5 mutants in S. pombe?

Creating and validating Spt5 mutants in S. pombe requires careful consideration of both technical approaches and functional assays:

  • Mutation design strategies:

    • Structure-guided mutations: Target specific residues based on available structural data

    • Conservation-based approach: Focus on residues conserved across species

    • Alanine-scanning: Systematically replace clusters of charged residues with alanine

    • Domain deletion/truncation: Generate a series of domain deletions or truncations

  • Genomic integration methods:

    • Base strain selection: Use a background strain that allows for controlled expression and selection

    • CRISPR-Cas9: For precise genomic editing without leaving selection markers

    • Homologous recombination: Traditional approach with marker insertion/removal

    • Two-step integration: First integrate a URA3 marker, then replace with mutation via 5-FOA selection

  • Expression systems:

    • Endogenous locus replacement: Maintain native regulation but challenging for essential genes

    • Plasmid-based expression: Use alongside AID-mediated depletion of endogenous Spt5

    • Regulatable promoters: nmt1 promoter series allows for titratable expression levels

    • Integration at ectopic loci: Integrating at leu1 or ura4 loci preserves the native gene

  • Validation approaches:

    • Complementation testing: Assess rescue of growth defects in spt5-depleted strains

    • Western blot analysis: Confirm expression levels and stability of mutant proteins

    • Transcriptome analysis: RNA-seq to determine effects on gene expression patterns

    • ChIP-seq: Map localization changes of mutant Spt5 and effects on RNAPII distribution

    • Genetic interaction analysis: Test interaction with known Spt5 partners like Spt4

  • Functional assays:

    • Temperature sensitivity: Test growth at different temperatures (25°C, 30°C, 37°C)

    • Drug sensitivity: Assess growth on media containing 6-azauracil or mycophenolic acid

    • Antisense transcription: Measure antisense transcript levels via strand-specific RT-PCR

    • Splicing efficiency: Monitor pre-mRNA splicing through intron retention measurements

    • rRNA synthesis: Quantify nascent rRNA production using the ITS1 region as reporter

  • Controls and standards:

    • Wild-type Spt5: Essential positive control for all experiments

    • Known mutants: Include characterized mutants like spt5-ΔCTR as standards

    • spt4Δ background: Test mutations in both SPT4+ and spt4Δ backgrounds to reveal synthetic interactions

Research has demonstrated the effectiveness of these approaches, for example, in showing that as few as three nonamer repeats of the Spt5 CTD are sufficient for S. pombe growth when Spt4 is present .

What approaches can be used to analyze genetic interactions between Spt5 and other transcription factors in S. pombe?

Analyzing genetic interactions between Spt5 and other transcription factors requires systematic approaches to reveal functional relationships:

  • Double mutant analysis:

    • Generate double mutants combining Spt5 domain mutants with mutations in other factors

    • Assess synthetic lethality, sickness, or suppression phenotypes

    • Example: The synthetic lethality of spt5(1-835) spt4Δ at 34°C revealed functional overlap between Spt4 interaction and the Spt5 CTD

    • Quantitative assessment of growth rates in liquid culture provides more sensitive detection of genetic interactions

  • Systematic genetic screens:

    • Adapt synthetic genetic array (SGA) methodology for S. pombe

    • Cross Spt5 mutants with deletion/mutation libraries

    • Use barcode sequencing to enable pooled screens for genetic interactions

    • Prioritize screening against factors involved in transcription, chromatin modification, and RNA processing

  • Conditional genetic interaction analysis:

    • Combine AID-tagged Spt5 with temperature-sensitive alleles of other factors

    • Titrate depletion levels by varying auxin concentration

    • Identify threshold effects where partial loss of both factors causes synergistic defects

    • Test interactions under various stress conditions (temperature, nutrient limitation, DNA damage)

  • Dosage suppression screening:

    • Overexpress libraries of transcription factors in Spt5 mutant backgrounds

    • Identify factors that can compensate for Spt5 deficiency when overexpressed

    • This approach can reveal factors acting downstream or in parallel pathways

  • Factor recruitment analysis:

    • Perform ChIP-seq for various factors in wild-type and Spt5 mutant backgrounds

    • Identify factors whose recruitment depends on Spt5

    • Example: Testing Paf1 complex recruitment in Spt5 mutants, as Spt5 is known to affect Paf1 recruitment

  • Multi-omics integration:

    • Combine genetic interaction data with transcriptome, ChIP-seq, and protein interaction data

    • Build network models of functional relationships

    • Use clustering approaches to identify factors that share genetic interaction profiles with Spt5

  • Targeted analysis of pathway components:

    • Focus on factors in specific pathways:

      • Transcription initiation factors (Mediator, TFIIH)

      • Elongation factors (TFIIS, PAF complex, FACT)

      • Chromatin modifiers (Set1, Set2, HDAC complexes)

      • RNA processing factors (capping enzymes, splicing factors)

      • Termination factors (CPF, Rat1/Dhp1)

These approaches have successfully revealed functional relationships, such as the connection between Spt5 depletion and antisense transcription, which occurs through a mechanism distinct from other known antisense-regulating pathways involving the Paf1 complex, H3K4 trimethylation, Spt6, and the nuclear exosome .

How can Spt5 research in S. pombe contribute to understanding transcription-associated diseases in humans?

Research on S. pombe Spt5 offers valuable insights into human transcription-related diseases through multiple translational pathways:

  • Conserved molecular mechanisms: The fundamental functions of Spt5 in transcription elongation are highly conserved from yeast to humans. Discoveries in S. pombe regarding:

    • Barrier region passage requirements

    • Antisense transcription suppression

    • Co-transcriptional processing regulation
      All provide directly applicable insights into human SUPT5H function .

  • Disease-associated mutations: Several human neurodevelopmental disorders and cancers harbor mutations in SUPT5H. S. pombe provides an excellent platform to:

    • Model equivalent mutations in a simplified genetic background

    • Assess effects on transcription genome-wide

    • Test for genetic interactions with disease-relevant pathways

    • Screen for suppressors that might suggest therapeutic approaches

  • Mechanistic basis for transcriptional dysregulation: Many diseases involve aberrant transcription regulation. S. pombe Spt5 research has revealed:

    • Mechanisms preventing antisense transcription

    • Control of RNA polymerase distribution across genes

    • Regulation of co-transcriptional processes like splicing
      These findings provide mechanistic frameworks for understanding disease states.

  • Drug target identification and validation: S. pombe offers advantages for discovering compounds that modulate transcription elongation:

    • Simplified genetic background compared to human cells

    • Ease of genetic manipulation

    • Growth-based high-throughput screens

    • Ability to generate resistant mutants to confirm targets

  • Stress response and cellular adaptation: Research in S. pombe has shown Spt5's critical role in cellular stress response:

    • Temperature sensitivity of spt4Δ mutants reveals stress-specific requirements

    • Regulation of co-transcriptional processes like splicing under stress
      These findings have implications for understanding human cellular adaptation to stress.

Future research directions should focus on creating more precise disease models in S. pombe by introducing specific mutations equivalent to human disease variants, and using multi-omics approaches to characterize their effects on transcription, RNA processing, and cellular physiology.

What are the current technical limitations in studying Spt5 function and what emerging technologies might overcome these barriers?

Current technical limitations and potential solutions in Spt5 research include:

  • Temporal resolution challenges:

    • Current limitation: Most depletion methods (including AID) require 30-60 minutes, making it difficult to distinguish primary from secondary effects.

    • Emerging solutions:

      • Improved AID systems with OsTIR1F74A and 5-Ad-IAA for faster degradation

      • Optogenetic degron systems allowing light-activated, reversible inactivation

      • Chemical genetics approaches with engineered drug-sensitive Spt5 variants

  • Protein complex structural characterization:

    • Current limitation: Full structural understanding of the Spt5-Spt4 complex in elongating transcription complexes remains incomplete.

    • Emerging solutions:

      • Advances in cryo-EM enabling structure determination of dynamic complexes

      • Integrative structural biology combining crystallography, NMR, and computational modeling

      • In-cell structural techniques like FRET-based sensors and cross-linking mass spectrometry

  • Single-molecule analysis in vivo:

    • Current limitation: Bulk assays mask heterogeneity in Spt5's effects on individual transcription units.

    • Emerging solutions:

      • Live-cell single-molecule tracking of Spt5 and RNAPII

      • Nascent RNA labeling techniques like MCP-MS2 systems

      • Single-cell multi-omics approaches to correlate transcription, chromatin state, and protein interactions

  • Transient interactions detection:

    • Current limitation: Many Spt5 interactions may be transient and context-dependent, making them difficult to detect.

    • Emerging solutions:

      • Proximity labeling techniques like TurboID and APEX2

      • Time-resolved cross-linking methods

      • Advanced co-immunoprecipitation techniques with stabilizing cross-linkers

  • Functional domain mapping resolution:

    • Current limitation: Current approaches often rely on large domain deletions that may disrupt multiple functions.

    • Emerging solutions:

      • CRISPR-based saturating mutagenesis of Spt5

      • Deep mutational scanning paired with functional selection

      • Domain-specific chemical genetics with engineered sensitivities

  • Nucleic acid structure and dynamics:

    • Current limitation: Understanding how Spt5 interacts with and affects RNA structures during transcription remains challenging.

    • Emerging solutions:

      • Advanced RNA structure probing techniques (SHAPE-MaP, DMS-MaPseq)

      • Single-molecule FRET to monitor structural transitions

      • Molecular dynamics simulations informed by experimental constraints

These technological advances will help overcome the current limitations in understanding the complex and multifaceted roles of Spt5 in transcription regulation across different biological contexts.

What are the most promising directions for future research on S. pombe Spt5?

Future S. pombe Spt5 research directions with significant potential include:

  • Mechanistic investigation of the transcription barrier:

    • Detailed molecular characterization of the +500 bp barrier region where RNAPII accumulates after Spt5 depletion

    • Identification of sequence features, chromatin states, or RNA structures that contribute to this barrier

    • Development of in vitro systems to reconstitute barrier-specific elongation defects

    • This would address fundamental questions about how Spt5 facilitates elongation past regulatory checkpoints

  • Antisense transcription regulation mechanisms:

    • Comprehensive mapping of antisense transcription initiation sites genome-wide

    • Identification of factors that cooperate with Spt5 to suppress antisense transcription

    • Investigation of the fate and potential functions of antisense transcripts

    • Comparative analysis with other species to understand evolutionary conservation of these mechanisms

  • Spt5's role in RNA Polymerase I transcription:

    • Definitive characterization of the direct versus indirect effects of Spt5 on rRNA synthesis

    • Mapping the physical interactions between Spt5 and the Pol I machinery

    • Determination of whether Spt5-Spt4 functions similarly in Pol I and Pol II transcription

    • This addresses an important knowledge gap in understanding the full spectrum of Spt5 functions

  • Post-translational modifications of Spt5:

    • Comprehensive mapping of modifications on S. pombe Spt5

    • Functional characterization of CTD phosphorylation in various contexts

    • Identification of kinases, phosphatases, and other enzymes that modify Spt5

    • Comparison with modification patterns in other species to understand evolutionary divergence

  • Stress-responsive regulation of Spt5 function:

    • Investigation of how environmental stresses affect Spt5 activity and interactions

    • Characterization of stress-specific transcriptional programs requiring Spt5

    • Analysis of condition-specific genetic interactions

    • This would build on observations of temperature sensitivity in Spt5/Spt4 mutants

  • Integration with chromatin regulation:

    • Detailed analysis of how Spt5 coordinates with chromatin remodelers and modifiers

    • Investigation of histone modification patterns affected by Spt5 depletion

    • Characterization of the relationship between nucleosome positioning and Spt5-dependent elongation

    • This would provide insights into the chromatin-transcription interface

  • Systems-level understanding of Spt5 function:

    • Network analysis integrating genetic, physical, and functional interactions

    • Mathematical modeling of transcription elongation with and without Spt5

    • Comparative analysis across species to identify core versus species-specific functions

    • This would place Spt5 in the broader context of cellular regulation

These research directions hold promise for revealing fundamental principles of transcription regulation that extend beyond S. pombe to inform our understanding of eukaryotic gene expression more broadly.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.